Sun Pharmaceutical Industries

SUNPHARMA

Option chain

₹ 1,836.23

₹ 11.85

0.64%

Modeled data

Sun Pharmaceutical Industries
Market Sentiment

Timeline	Returns	Volume
Daily	0.64%	27,05,903
Weekly	2.44%	56,18,834
Monthly	7.24%	1,90,98,510

Sun Pharmaceutical Industries
Performance

Timeline	Daily	Weekly	Monthly
SUNPHARMA	0.64%	2.44%	7.24%
Index	-	-	-
Peer Avg.	-0.47%	1.20%	12.08%

*Avg of index constituents

Sun Pharmaceutical Industries
Fundamentals

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
SUNPHARMA	67.07	6.75	21.51	3.41	5.72	0.97
Index	35.44	5.98	16.81	16.99	18.41	1.19
Peer Avg.	38.60	4.35	13.48	12.96	16.49	0.78

*Avg of index constituents

Sun Pharmaceutical Industries
Key Metrics

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	12.90%	-31.40%	3.41%	5.72%
FY '20-21	7.33%	-59.60%	4.13%	4.56%
FY '19-20	17.30%	161.85%	11.63%	11.13%

Sun Pharmaceutical Industries
Shareholding Pattern

Promoters : 54.48%

FII : 14.44%

DII : 20.02%

Public : 11.06%

Others : 0%

Sun Pharmaceutical Industries
Profit & Loss

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	27,120.24	20,845.05	7,592.34	1,652.91
FY '20-21	23,807.10	18,444.73	5,887.98	1,563.54
FY '19-20	22,684.72	17,841.81	5,924.15	3,698.97

All values are in crores

Sun Pharmaceutical Industries
Peer Comparison

Metrics	Sales	Expenditure	EBITDA	PAT
SUNPHARMA	27,120.24	20,845.05	7,592.34	1,652.91
DIVISLAB	8,919.83	5,041.89	3,992.91	2,954.49
CIPLA	17,427.56	13,488.35	4,433.43	2,624.43

All values are in crores

Sun Pharmaceutical Industries Share Price

Sun Pharmaceutical Industries Limited is a company specialised in the production of generic drugs. The field of activity of the company is the production, development and marketing of various generic preparations. It produces a range of generic and specialty medicines targeting a wide range of chronic and acute treatments. The company's product portfolio includes generics, branded generics, specialty products, OTC/consumer health products, antiretrovirals (ARVs), active pharmaceutical ingredients (APIs) and intermediates. Its OTC brands include Faringosept, Revital and Volini. The company offers its products in several different dosage forms such as tablets, capsules, sprays, injections, inhalers, ointments, creams and liquids. Its special product portfolio, generic brands are available in 100 countries. The company has production facilities on 6 continents.

Sun Pharmaceutical Industries FAQs

How to Buy Sun Pharmaceutical Industries Share?

To purchase Sun Pharmaceutical Industries shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Sun Pharmaceutical Industries (ticker symbol: SUNPHARMA) on the trading platform provided by your broker and purchase the shares.

What's Sun Pharmaceutical Industries share price today?

The stock price of Sun Pharmaceutical Industries as of 16 Sep 2024 is ₹1,836.23

What is the Market Cap of Sun Pharmaceutical Industries?

Market capitalisation represents the total market value of a company's outstanding shares. As of 16 Sep 2024, Sun Pharmaceutical Industries (ticker symbol: SUNPHARMA) has a market capitalisation of approximately ₹24,72,63,46,53,333.50

What is the PE and PB ratio of Sun Pharmaceutical Industries?

Sun Pharmaceutical Industries Ltd's price-to-book ratio as of 16 Sep 2024 is 6.7491226, reflecting the market's valuation compared to its asset value. As of 16 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 67.06548, indicating the market values the company at around ₹67.07 for every ₹1 of earnings